Vaccinex, Inc. (VCNX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:45AM EDT. Market open.
| Previous close | 5.89 |
| Open | 6.29 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 6.29 - 6.74 |
| 52-week range | 4.43 - 100.80 |
| Volume | |
| Avg. volume | 13,745 |
| Market cap | 10.678M |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Steven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Inc
Point72 Asset Management, led by renowned investor Steven Cohen (Trades, Portfolio), has recently initiated a position in Vaccinex Inc (NASDAQ:VCNX), a biotechnology company focused on cancer and neurodegenerative disease treatment. On February 6, 2024, the firm acquired 1,631,648 shares of Vaccinex Inc, marking a new holding in its investment portfolio. The shares were purchased at a price of $0.5863 each, reflecting a significant move by the firm into the biotech sector.
© 2024 Yahoo. All rights reserved.